Replies to post #269448 on Amarin Corp Plc (AMRN)

[caddiedad]

As in BP, collectively, is in this together to slow down Vascepa? Not obvious to me. All you need is one buyer, just like in real estate. It doesn't take multiple players to do a deal. Nothing I've said is new or enlightening.

BTW...I'll also sell all my shares at the current "Ask" of $29 (in the lower right corner of this page) if one wants to contact me.

[north40000]

Some “similar drug” has not appeared from BP in several years to date, has it?!

I think a “similar drug” would be some molecule that is administered to patients in substantially the same way to obtain substantially the same result as Amarin has achieved(and will achieve) in the CVD and other market places(I include cost to healthcare system in my calculus for result). Have you or anyone else seen anything fitting that broad definition or algorithm appearing from any entity?

As for the immediate generics of concern, have you seen any bailout or funding being supplied by anyone or any entity to R,H or T? India, UK, Israel and/or U.S.?